Please assess the completion status of the following clinical trial:

Trial Title: Immunostimulating Interstitial Laser Thermotherapy in Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Have histologically confirmed breast cancer~2. Hormone receptor positive or negative~3. Have assessable tumour by MRI or ultrasound~4. Are patients deemed unfit for surgical excision of tumour under general anaesthetic.~5. Have been given informed verbal and written consent for participation in the trial~6. Have stable hematologic, renal and hepatic functions.~Exclusion Criteria:~1. Are known to be HIV positive~2. Have active autoimmune disease~3. Are on corticosteroid medication~4. Have evidence of bleeding diathesis or coagulopathy.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- imILT (Type: EXPERIMENTAL): Immunostimulating Interstitial Laser Thermotherapy (imILT)

Based on this trial design, predict the completion outcome and termination type (if applicable).